Design of a NKG7 silencing regimen for treatment of treatment resistant very-early onset or early onset IBD.

Zenodo (CERN European Organization for Nuclear Research) 2026 Preprint Open access

Read full text
Authors: Shahan Mamoor
DOI: 10.5281/zenodo.18286733
Cited by: 0

Abstract

This document describes design of a NKG7 silencing regimen for treatment of treatment resistant very-early onset or early onset IBD.

Fields of Study & Subjects

Inflammatory Bowel Disease Cancer Immunotherapy and Biomarkers RNA Interference and Gene Delivery

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
18 January 2026
Document type
Preprint